EWA
IMNM icon

EverSource Wealth Advisors’s Immunome IMNM Stock Holding History

EverSource Wealth Advisors’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$131 Buy
+6
New +$134 ﹤0.01% 4241
2025
Q3 		– Sell
-8
Closed -$74 – 4398
2025
Q2 		$74 Sell
8
-61
-88% -$500 ﹤0.01% 4161
2025
Q1 		$464 Buy
+69
New +$662 ﹤0.01% 3484

Other funds holding IMNM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return

EverSource Wealth Advisors's IMNM Position: Q1 2026 in Review

EverSource Wealth Advisors opened a new position in Immunome (IMNM) in Q1 2026: 6 shares worth $131. The stake represents ﹤0.01% of the portfolio and ranks #4241 among its holdings. This is a return to the name: EverSource Wealth Advisors previously reported a position in IMNM as recently as Q2 2025.

EverSource Wealth Advisors first reported a position in IMNM in Q1 2025 and has held it in 3 quarters since. The position peaked at $464 in Q1 2025. 200 funds tracked by Wall St. Rank hold IMNM as of Q1 2026.

  • EverSource Wealth Advisors held 6 shares of Immunome worth $131 as of Q1 2026.
  • Immunome was a new EverSource Wealth Advisors position in Q1 2026.
  • Immunome made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q1 2026, its #4241 holding.
  • EverSource Wealth Advisors first reported a position in Immunome in Q1 2025 and has held it in 3 quarters since.
  • EverSource Wealth Advisors's Immunome position peaked at $464 in Q1 2025.
  • 200 funds tracked by Wall St. Rank held Immunome as of Q1 2026.

Based on EverSource Wealth Advisors's 13F filing for Q1 2026, filed 14 May 2026.